Eledon Pharmaceuticals, Inc. Deferred Tax Liabilities, Gross
Eledon Pharmaceuticals, Inc. (ELDN) had Deferred Tax Liabilities, Gross of $7.77 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-19
- 2025-12-31: Deferred Tax Liabilities, Gross $7.77M.
- 2024-12-31: Deferred Tax Liabilities, Gross $7.84M.
- 2023-12-31: Deferred Tax Liabilities, Gross $7.77M.
- 2022-12-31: Deferred Tax Liabilities, Gross $7.96M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $7.77M 10-K · filed 2026-03-19 |
| 2024-12-31 | $7.84M 10-K · filed 2026-03-19 |
| 2023-12-31 | $7.77M 10-K/A · filed 2025-08-14 |
| 2022-12-31 | $7.96M 10-K/A · filed 2024-08-19 |
| 2021-12-31 | $7.36M 10-K · filed 2023-03-30 |
| 2020-12-31 | $6.83M 10-K · filed 2022-03-24 |
| 2019-12-31 | $66.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |